Bio Pharma Dive
MARCH 1, 2021
For marketers in the health space, cannabis and CBD consumers represent an audience that is in search of both alternative and conventional methods of well-being as their transformation from patient to participant accelerates.
World of DTC Marketing
MARCH 1, 2021
SUMMARY: Trust is earned every day. Today, because of the Internet, a lot of attention is placed on day-to-day activities. Pharma has to undress, and that trust is an ongoing process, and leaders cannot rest on the work they have completed, like developing vaccines. More support and improvement of processes are needed. The employees at J&J are saying, on LinkedIn, how proud they are that their company developed a COVID vaccine.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
XTalks
MARCH 1, 2021
Dry eye disease may sound innocuous, but it’s a condition that affects between 25 and 35 percent of individuals in the US, and pandemic-related lifestyle changes may be pushing that percentage up. Reports of a new condition dubbed “mask-associated dry eye” have been coming out of vision care centers in the country, prompting researchers to look at the effects of face masks on the delicate tear film responsible for protecting the eye.
BioPharma Reporter
MARCH 1, 2021
New data may have serious implications for the development of vaccination strategies for COVID-19, particularly in individuals with obesity.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
XTalks
MARCH 1, 2021
Pfizer Inc. (NYSE: PFE ) and BioNTech SE (Nasdaq: BNTX ) have announced that they are beginning a trial to evaluate the safety and efficacy of a third booster dose for their COVID-19 vaccine (BNT162b2), as well as new vaccine variants. The study is part of a broad development plan to assess the durability of the immunogenic responses elicited by its vaccine and the emergence of new SARS-CoV-2 variants.
BioPharma Reporter
MARCH 1, 2021
The Pfizer/BionTech COVID-19 vaccine â which requires ultra-cold storage â will now be allowed to be transported and stored at standard freezer temperatures for up to two weeks in the US.
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
Scienmag
MARCH 1, 2021
Credit: Sherry Harbin/Purdue University WEST LAFAYETTE, Ind. – New technology from Purdue University innovators may help improve tissue restoration outcomes for people with breast cancer and other diseases or traumatic injuries. Purdue researchers, along with fellowship-trained breast surgeon Carla Fisher of Indiana University School of Medicine, teamed up with Purdue startup GeniPhys to develop and […].
BioSpace
MARCH 1, 2021
Novavax Chief Executive Officer Stanley Erck believes the U.S. Food and Drug Administration could grant Emergency Use Authorization for its COVID-19 vaccine by May.
Scienmag
MARCH 1, 2021
Credit: Copyright 2021 AANS Charlottesville, VA (March 2, 2021). Researchers in the Perelman School of Medicine at the University of Pennsylvania conducted a prospective cohort study utilizing their technique of delayed near-infrared imaging with high-dose indocyanine green (called “second window ICG” or “SWIG”) in the identification of brain metastases during surgery.
BioSpace
MARCH 1, 2021
The biopharma industry remained strong, as demand for COVID-related products skyrocketed. However, some companies are facing layoffs. Here's a brief overview.
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
VirTrial
MARCH 1, 2021
Scottsdale, AZ (March 2, 2021) – VirTrial today announced the general availability of SmartSignals eConsent, a PDF-based, clinical trial consent solution offering rapid implementation and a flexible, scalable, and lightweight design. The product helps trial teams quickly set up e-consenting functionality and enables study sites to greatly reduce the effort to route and manage documents for signature.
pharmaphorum
MARCH 1, 2021
Roche Diagnostics has launched a 15-minute nasal antigen test for COVID-19 in the UK, and says it has millions of the kits available straight away to help the country recover from the pandemic. . The speedy test can turn around results within 15 minutes, without the need for processing swabs in a lab, and only requires the front part of the nose to be swabbed, rather than the nasopharynx area where the nose meets the throat.
BioSpace
MARCH 1, 2021
The U.S. FDA has decided to put together an advisory committee meeting of outside experts to review a New Drug Application for roxadustat, FibroGen and its partner AstraZeneca’s investigational anemia therapy.
Scienmag
MARCH 1, 2021
Credit: Virginia Tech Since 1970, bird populations in North America have declined by approximately 2.9 billion birds, a loss of more than one in four birds. Factors in this decline include habitat loss and ecosystem degradation from human actions on the landscape. At the same time, enthusiasm for bird-watching has grown, with more than 45 […].
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Pharma Marketing Network
MARCH 1, 2021
[link]. Blockchain technology has become an increasing tool for life science organizations. How is this technology being implemented, and what value does it offer? Join Darshan Kulkarni as he talks with guest Jim Nasr about the function of blockchain, and how distributed ledger technologies such as blockchain are making an impact on healthcare. The post DarshanTalks: Blockchain & Information Technology</br> – March 1, 2021 appeared first on Pharma Marketing Network.
BioSpace
MARCH 1, 2021
In a fourth quarter 2020 financial results announcement made on Monday, Inovio Pharmaceuticals said it has completed enrollment of 400 participants in its Phase II segment of the INNOVATE (INOVIO INO-4800 Vaccine Trial for Efficacy) Phase II/III trial.
Scienmag
MARCH 1, 2021
Informing practical strategies towards higher energy density batteries Credit: Dr Robert House, University of Oxford HARWELL, UK (1 March 2021) Scientists based at the University of Oxford as part of the Faraday Institution CATMAT project researching next-generation cathode materials have made a significant advance in understanding oxygen-redox processes involved in lithium-rich cathode materials.
Outsourcing Pharma
MARCH 1, 2021
A leader from the genetic solutions firm explains how genetic testing and counseling can help trial teams form more beneficial connections with patients.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Scienmag
MARCH 1, 2021
Many of the benefits people receive from nature depend on diversity within species, but this intraspecific variation is poorly understood and declining rapidly Credit: Simone Des Roches The rapid loss of variation within species is a hidden biodiversity crisis, according to the authors of a new study looking at how this variation supports essential ecological […].
Pharma Times
MARCH 1, 2021
Latest funding round includes investments from Foresite Capital and F-Prime Capital
Scienmag
MARCH 1, 2021
Credit: (Photo: Fabian Boetzl) Due to modern agriculture, biodiversity across many species groups is in decline. Over the last three decades, attempts have been made to counteract this with agri-environmental schemes at various levels – from the national federal state to EU-wide programmes. Not only out of appreciation of nature, but also because many species […].
BioSpace
MARCH 1, 2021
Eye disease company Oyster Point announced the New Drug Application for its dry eye disease therapy OC-01, submitted in December, has been accepted for regulatory review on the back of positive Phase III data.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
Scienmag
MARCH 1, 2021
Researchers modified the existing SIR class pandemic prediction model. Credit: Peter the Great St.Petersburg Polytechnic University A painful tradeoff between a number of infected and negative economic impact must be considered before deciding on the lockdown strategy within a city. As national economies continue to crumble, citizens wonder whether their governments did a good job […].
XTalks
MARCH 1, 2021
Cheez-It introduced a new Loaded Popcorn that makes a great addition to at-home movie nights. With families being unable to go to movie theatres during the pandemic, the brand released a cheesy flavored popcorn that replicates the ones found at the cinema. The Cheez-It Loaded Popcorn is made with 100 percent real cheese and comes in two flavors: Cheez-It Loaded Cheddar Popcorn and Cheez-It Loaded White Cheddar Popcorn. “Even though our Cheez-It Original crackers are a tried-and-true classi
Scienmag
MARCH 1, 2021
Rutgers research shows stormwater could be important source of plastic pollution Credit: NOAA Rutgers scientists for the first time have pinpointed the sizes of microplastics from a highly urbanized estuarine and coastal system with numerous sources of fresh water, including the Hudson River and Raritan River. Their study of tiny pieces of plastic in the […].
Pharma Times
MARCH 1, 2021
Company found to have broken competition law to drive up prices of antidepressant nortriptyline
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Scienmag
MARCH 1, 2021
Credit: Johan Wingborg In recent years, techniques have been developed to treat diseases with what are known as oligonucleotide drugs, based on short DNA or RNA molecules. The Wallenberg Centre for Molecular and Translational Medicine at the University of Gothenburg has now been awarded SEK 54 million by the Knut and Alice Wallenberg Foundation, and […].
Pharma in Brief
MARCH 1, 2021
On February 24, 2021, Parliament voted down Bill C-213 , which would have enacted the Canada Pharmacare Act. The Private Member’s Bill was first introduced a year ago, re-introduced in September 2020 after Parliament’s prorogation, and defeated at Second Reading. The Canada Pharmacare Act set out a series of criteria and conditions that would have been required before a federal cash contribution could be provided to a province for its public drug insurance plan: public administration; comprehens
Scienmag
MARCH 1, 2021
Credit: SPOT/Monk Seal Project Scientists have discovered a previously unknown breeding site used by the world’s rarest seal species. The Mediterranean monk seal is classified as “endangered”, with a total population of about 700. The new study – by the University of Exeter and the Society for the Protection of Turtles (SPOT) – used camera-traps […].
BioSpace
MARCH 1, 2021
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for March 2, 2021.
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
246 
Let's personalize your content